Skip to main content
. 2020 Aug 21;18:587–601. doi: 10.1016/j.omto.2020.08.009

Figure 1.

Figure 1

ICAM-1 Expression Is Associated with Poor Prognosis in Gastric Cancer Patients

(A) ICAM-1 expression was graded as negative (0) (i), weak (1, light brown) (ii), moderate (2, brown) (iii) or strong (3, dark brown) (iv). Scale bars, 20 μm. (B and C) Kaplan-Meier plots indicating a significant difference in disease-free survival (B) and overall survival (C) between ICAM-1 (blue lines) and ICAM-1+ (green lines) gastric cancer patients (n = 134).